<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended January 31, 1996 or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File No. 0-20488
PMR CORPORATION
---------------
(Exact name of registrant as specified in its charter)
Delaware 23-2491707
-------------------- --------------------
(State or other (I.R.S. Employer
jurisdiction of Identification
incorporation or Number)
organization)
3990 Old Town Avenue, Suite 206A, San Diego, California, 92110
--------------------------------------------------------------
(Address of principal executive offices, including zip code)
(619) 295-2227
--------------
Registrant's Telephone No., Including Area Code)
N/A
---
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports) and (2) has been subject to such
filing requirements for the past 90 days.
(1) Yes X No
----- -----
(2) Yes X No
----- -----
As of March 14, 1996 the Registrant has issued and outstanding 3,547,149 shares
of common stock, par value $.01 per share.
<PAGE> 2
PMR CORPORATION
INDEX
<TABLE>
<S> <C> <C>
PART I FINANCIAL INFORMATION Page
Item 1. Consolidated Condensed Balance Sheets as of
January 31, 1996 (Unaudited) and April 30, 1995 1
Consolidated Condensed Statements of Operations
for the three and nine months ended January
31, 1996 and 1995 (Unaudited) 2
Consolidated Condensed Statements of Cash Flows
for the nine months ended January 31, 1996 and
1995 (Unaudited) 3
Notes to Consolidated Condensed Financial
Statements (Unaudited) 4
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations 5
</TABLE>
PART II OTHER INFORMATION
<TABLE>
<S> <C> <C>
Item 1. Legal Proceedings 11
Item 2. Changes in Securities 11
Item 3. Defaults Upon Senior Securities 11
Item 4. Submission of Matters to a Vote
of Security Holders 11
Item 5. Other Information 11
Item 6. Exhibits and Reports on Form 8-K 11
</TABLE>
<PAGE> 3
PMR Corporation and Subsidiaries
Consolidated Condensed Balance Sheets
<TABLE>
<CAPTION>
January 31 April 30
1996 1995
----------- -----------
(Unaudited)
<S> <C> <C>
Assets
Current assets:
Cash and cash equivalents $ 1,688,710 $ 1,382,376
Notes and accounts receivable, net 12,505,408 8,465,568
Prepaid expenses and other current assets 264,355 289,996
Refundable income tax benefits 817,159 817,165
Deferred income tax benefits 1,217,000 1,217,000
----------- -----------
Total current assets 16,492,632 12,172,105
Furniture and office equipment, less accumulated depreciation
of $817,378 in January 1996 and $579,656 in April 1995 673,721 790,243
Long-term receivables 419,705 937,705
Other assets 2,005,667 910,701
----------- -----------
$19,591,725 $14,810,754
=========== ===========
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and other liabilities $ 2,192,762 $ 1,114,134
Accrued compensation and benefits 1,693,241 861,029
Note payable to bank 800,000 1,200,000
Current portion of long term debt 157,766 206,550
----------- -----------
Total current liabilities 4,843,769 3,381,713
Reserve for contract settlement 5,410,999 3,523,223
Deferred income taxes 425,200 458,000
Other long term liabilities 363,821 386,225
Commitments
Stockholders' equity:
Common Stock, $.01 par value, authorized shares -
10,000,000; issued and outstanding shares - 3,547,149
in January 1996; 3,338,656 in April 1995. 35,471 33,385
Convertible preferred stock, $.01 par value,
authorized shares - 1,000,000
Series C - issued and outstanding - 700,000 shares
(aggregate liquidation preference $1,750,000) 7,000 7,000
Paid-in capital 8,116,216 7,050,262
Notes receivable from shareholders (39,351) (62,626)
Retained earnings 428,600 33,572
----------- -----------
8,547,936 7,061,593
----------- -----------
$19,591,725 $14,810,754
=========== ===========
</TABLE>
See notes to consolidated condensed financial statements.
Page 1
<PAGE> 4
PMR Corporation and Subsidiaries
Consolidated Condensed Statements of Operations
(Unaudited)
<TABLE>
<CAPTION>
Third Quarter Year-to-Date
-------------------------- ----------------------------
Three Months Ended Nine Months Ended
January 31 January 31
1996 1995 1996 1995
----------- ---------- ----------- -----------
<S> <C> <C> <C> <C>
Management fees & other revenues $10,154,252 $5,107,489 $24,374,956 $17,262,307
Expenses
Operating expenses 8,462,791 5,121,831 19,674,822 15,731,323
Marketing, general and administrative 914,496 840,437 2,798,106 2,513,284
Provision for bad debts 233,921 162,000 645,489 603,427
Depreciation and amortization 151,680 106,782 417,832 303,865
Interest - net (46,048) 15,146 1,330 11,012
Minority interest in loss of subsidiary - (44,701) (524) (136,339)
----------- ---------- ----------- -----------
9,716,840 6,201,495 23,537,055 19,026,572
Income (loss) before income taxes 437,412 (1,094,006) 837,901 (1,764,265)
Less income tax expense (benefit) 182,000 (453,000) 344,000 (723,000)
----------- ---------- ----------- -----------
Net income (loss) 255,412 (641,006) 493,901 (1,041,265)
Less dividends on:
Series C convertible preferred stock 32,813 32,813 98,873 32,813
----------- ---------- ----------- -----------
Net income (loss) for common stock $222,599 $(673,819) $395,028 $(1,074,078)
=========== ========== =========== ===========
Earnings (loss) per common share
Primary $ .06 $ (.20) $ .11 $ (.32)
=========== ========== =========== ===========
Fully diluted $ .06 $ (.20) $ .11 $ (.32)
=========== ========== =========== ===========
Shares used in computing earnings
Primary 4,556,745 3,338,004 4,419,810 3,337,106
=========== ========== =========== ===========
Fully diluted 4,556,745 3,338,004 4,450,528 3,337,106
=========== ========== =========== ===========
</TABLE>
See notes to consolidated condensed financial statements.
Page 2
<PAGE> 5
PMR Corporation and Subsidiaries
Consolidated Condensed Statements of Cash Flows
(Unaudited)
<TABLE>
<CAPTION>
Third Quarter
---------------------------
Nine Months Ended
January 31
1996 1995
---------- -----------
<S> <C> <C>
OPERATING ACTIVITIES
Net income (loss) $493,901 $(1,041,265)
Adjustments to reconcile net income (loss) to
net cash used by operating activities:
Provision for bad debts 645,489 603,427
Depreciation and amortization 417,832 303,865
Provision (benefit) for deferred taxes 344,000 (723,000)
Changes in operating assets and liabilities:
Accounts receivable (4,167,329) (6,009,964)
Other assets (176,819) (376,748)
Accounts payable and accrued compensation 1,976,378 (387,991)
Reserve for contract settlement 1,887,776 1,870,150
Other liabilities (315,881) (107,176)
---------- -----------
NET CASH PROVIDED BY (USED IN)
OPERATING ACTIVITIES 1,105,347 (5,868,702)
INVESTING ACTIVITIES
Purchases of furniture and equipment (123,049) (141,910)
---------- -----------
NET CASH USED IN INVESTING ACTIVITIES (123,049) (141,910)
FINANCING ACTIVITIES
Proceeds from sale of preferred stock 1,583,059
Proceeds from sale of common stock 132,513
Proceeds from note payable to bank 2,800,000
Payments on note payable to bank (400,000) (1,600,000)
Payments on long term debt (153,575) (193,742)
Payment of dividends on preferred stock (126,935) -
Proceeds from exercise of warrants & options 4,546 -
---------- -----------
NET CASH PROVIDED BY (USED IN)
FINANCING ACTIVITIES (675,963) 2,721,830
---------- -----------
NET INCREASE (DECREASE) IN
CASH AND CASH EQUIVALENTS $306,334 $(3,288,782)
========== ===========
</TABLE>
See notes to consolidated condensed financial statements.
Page 3
<PAGE> 6
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (UNAUDITED)
PMR CORPORATION AND SUBSIDIARIES
January 31, 1996
NOTE A - BASIS OF PRESENTATION
The accompanying unaudited financial statements have been prepared in
accordance with generally accepted accounting principles for interim financial
information and with the instructions to Form 10-Q and Rule 10-01 of Regulation
S-X. Accordingly, they do not include all of the information and footnotes
required by generally accepted accounting principles for complete financial
statements. In the opinion of management, all adjustments (consisting of
normal recurring accruals) considered necessary for a fair presentation have
been included. For purposes of computing earnings per share, the Series C
Preferred Stock is a common stock equivalent and conversion is assumed except
when anti-dilutive. Operating results for the three and nine months ended
January 31, 1996, are not necessarily indicative of the results that may be
expected for the year ending April 30, 1996. For further information, refer to
the financial statements and footnotes thereto included in the Company's Annual
Report on Form 10-K for the year ended April 30, 1995.
NOTE B - ACQUISITION OF MINORITY INTEREST IN SUBSIDIARY
On July 13, 1995, the Company acquired the 49% partnership interest in the Twin
Town Outpatient partnership formerly held by a third party by paying $185,000
in cash and 97,087 shares of the Company's Common Stock valued at $550,000.
Prior to that date, the Company owned a 51% interest in the partnership which
resulted in consolidation for financial statement purposes.
NOTE C - CASE MANAGEMENT AGREEMENTS
The Company entered into management agreements with two case management
agencies in Tennessee, effective September 1 and October 1, 1995, respectively.
The Company has agreed to issue 50,000 shares of the Company's Common Stock,
valued at $225,000 and $256,250, respectively, to each agency in connection
with the agreements.
Page 4
<PAGE> 7
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
GENERAL
PMR Corporation (the "Company") is a manager of programs which treat the
diseases that comprise Serious and Persistent Mental Illness (SPMI). These
diseases are primarily Schizophrenia and Bipolar Disorder (Manic Depression).
In addition, the Company manages chemical dependency programs.
The Company's programs are outpatient and community based. They focus on
limiting hospitalization and returning the mentally disabled back to work, or
into other productive activities. The Company manages three distinct types of
programs.
First, PMR engages in the development and management of outpatient acute
psychiatric programs (Programs) which include partial hospitalization programs.
These are intensive outpatient treatment programs designed for SPMI individuals
as an alternative to inpatient acute care. These Programs are operated in
conjunction with Hospitals or Community Mental Health Centers (CMHCs), "the
Providers." During the third quarter, the Company commenced operations in one
new market area, re-opened one site with a new Provider and re-opened the fourth
San Diego site in a new location.
Second, the Company manages a complete mental health benefit for the SPMI
individuals and has expanded its focus to compete within the managed care
segment of the industry. In line with its strategic goals, during the second
quarter of fiscal year 1996, the case management subsidiary began operating in
September in Nashville and a second site was initiated in Memphis in October.
During the third quarter, the Company signed a General Enabling Agreement with a
consortium of CMHCs in Arkansas. Case management for SPMI is continual face to
face contacts with patients in the home, community or office. The case manager
assists with access to all health care, social and daily living services needed
to sustain living in the community. It is believed to be the essential service
required for SPMI in a managed care environment.
Third, the Company, through its subsidiary, Twin Town Outpatient, provides
outpatient chemical dependency treatment services from detoxification to
rehabilitation and recovery principally for the commercial managed care market.
During the third quarter, Twin Town Outpatient began the management of the first
ambulatory detoxification program for public sector patients in Arkansas.
Page 5
<PAGE> 8
RESULTS OF OPERATIONS
Third Quarter Operations
During the third quarter of fiscal year 1996, the Company earned $223,000
on net revenues of $10.2 million. Comparable figures for the equivalent prior
year period reflected a loss of $674,000 on net revenue of $5.1 million. Net
revenue for the nine months was 99% higher than the net revenue in the
equivalent prior year period, primarily as the result of revenue from the case
management subsidiary of approximately $3.0 million and the improved net
revenue per patient and improved margins in the outpatient acute psychiatric
programs. Patient census in the outpatient acute psychiatric program was up
40% from the equivalent prior year period, but net revenue was up 51%,
reflecting an improvement in net revenue per patient of 23%. The outpatient
acute psychiatric program's "same store" statistics were: an increase in
patient census of 35%, an increase in net revenue of 39%, an increase in
operating expenses of 18%, and an increase in gross margin of 105%. Net
revenue for chemical dependency treatment services was unchanged from the
equivalent prior year period.
Operating expenses. Operating expenses for the quarter of $8.4 million,
up $3.3 million, reflected a 65% increase from the equivalent prior year
period, also primarily as the result of the case management subsidiary's
operating expenses of approximately $2.7 million. Operating expenses were 83%
of net revenue for the current quarter compared to 100% of net revenue for the
equivalent prior year period. Outpatient acute psychiatric program expenses
increased 21% from the equivalent prior year period, but decreased 1% on a per
patient basis.
Marketing, general and administrative expenses. Marketing, general and
administrative expenses increased $74,000 or 9%, due to the administrative
costs associated with the addition of the case management subsidiary
operations. Marketing, general and administrative expenses have decreased from
16% of revenue in the equivalent prior year quarter to 9% of revenue in the
current quarter.
Depreciation and amortization. Depreciation and amortization increased
$45,000 or 42% primarily as the result of the amortization of the covenants not
to compete associated with the acquisition of all of the other partner's
interest in the Twin Town Outpatient subsidiary.
Interest - net. Net interest earned is a reflection of the improved cash
collections and interest earned on notes receivable as well as the result of
the decrease in debt and the increase in cash available for investment.
Dividends. The Company accrued dividends on its Series C Convertible
Preferred Stock at the rate of 7.5% per annum.
Page 6
<PAGE> 9
Nine Month Operations
For the nine months ended January 31, 1996, the Company earned $395,000 on
net revenue of $24.4 million. Comparable figures for the equivalent prior year
period reflected a loss of $1.1 million on net revenue of $17.3 million. Net
revenue for the nine months was 41% higher than the net revenue in the
equivalent prior year period, primarily as the result of revenue from the case
management subsidiary of approximately $4.5 million and the improved net
revenue per patient and improved margins in the outpatient acute psychiatric
programs. In addition, volume in the outpatient acute psychiatric programs was
up 17% from the equivalent prior year period, but net revenue was up 26%,
reflecting an improvement in net revenue per patient of 8%. The outpatient
acute psychiatric program's "same store" results were: an increase of 12% in
patient census, an increase in net revenue of 15%, an increase in operating
expenses of 5%, and an increase in gross margin of 38%. Net revenue for
chemical dependency treatment services was up 9% from the equivalent prior year
period.
Operating expenses. Operating expenses for the nine months of $19.7
million reflected a 25% increase from the equivalent prior year period,
primarily as the result of operating expenses of the case management subsidiary
of approximately $4.1 million. Operating expenses were 81% of net revenue for
the year-to-date compared to 91% of net revenue for the equivalent prior year
period. Outpatient acute psychiatric program expenses increased 9% from the
equivalent prior year period, but decreased 6% on a per patient basis.
Marketing, general and administrative expenses. Marketing, general and
administrative expenses increased $285,000 or 11%, due to the administrative
costs associated with addition of the case management subsidiary operations.
Marketing, general and administrative expenses have decreased from 15% of
revenue in the equivalent prior year period to 11% of revenue in the current
period.
Depreciation and amortization. Depreciation and amortization increased
$114,000 or 38% primarily as the result of the amortization of the covenants
not to compete associated with the acquisition of all of the other partner's
interest in the Twin Town Outpatient subsidiary.
Interest - net. Net interest earned is a reflection of the improved cash
collections and interest earned on notes receivable as well as the result of
the increase in cash and the decrease in debt.
Dividends. The Company accrued dividends on its Series C Convertible
Preferred Stock at the rate of 7.5% per annum.
Page 7
<PAGE> 10
LIQUIDITY AND CAPITAL RESOURCES
General
At January 31, 1996, the Company had $1,689,000 in cash available for
working capital purposes, an increase of approximately $307,000 from the end of
the prior fiscal year. Borrowings on the line of credit have been reduced to
$800,000. Management has arranged a new line of credit with Sanwa Bank
effective February 1, 1996 for a total commitment of $3.0 million at an
interest rate of either the bank's reference rate plus one or the Euro dollar
rate plus three. The expiration date is August 30, 1997.
The ratio of current assets to current liabilities of 3.4 at the end of
the current quarter compares to a ratio of 3.6 at April 30, 1995. The average
number of days' revenue in accounts receivable of 113 days at the end of the
current quarter has declined from 134 at April 30, 1995, and from 175 at the
end of the equivalent prior year period.
Working capital is anticipated to be utilized during the year to continue
expansion of the Company's outpatient acute psychiatric programs which
typically require $45,000 to $60,000 for office equipment, supplies, lease
deposits, and the hiring and training of personnel prior to opening as well as
for the implementation and expansion of other Company programs. New outpatient
acute psychiatric programs generally experience operating losses through an
average of the first four months of operation. The Company is obligated to
provide up to $1.0 million for operating expenses of the Tennessee operations
to the Company's case management subsidiary. In satisfaction of this
obligation, the Company provided $1.0 million in the second and third quarters
of the current fiscal year to fund the initial operations of the case
management subsidiary. Additional funding of approximately $400,000 may be
required in the fourth quarter for case management operations in Tennessee, but
subsequent operations are expected to be funded from cash collections of the
case management subsidiary. The Company expects to require additional funds
for the expansion or start up of additional case management operations, and
Management is exploring new sources of financing for expansion.
The Company, during the course of its ordinary business operations, from
time to time is faced with claims asserted by employees whose employment have
been terminated. Presently, one attorney represents two former employees who
have filed separate wrongful termination lawsuits against the Company. One of
these employees was involuntarily terminated by the Company and the other
voluntarily quit. The employee who was involuntarily terminated also filed a
complaint against the Company in the United States District Court, Northern
District of California, under the federal and state false claims acts alleging
the submission of false claims to Medicare. The complaint was filed on August
24, 1994, and was unsealed in June 1995. The United States declined to
intervene. The Company requested special counsel to review the assertions
regarding false claims. As a result of the Company's internal review and an
investigation performed by special counsel, management has concluded that these
lawsuits lack merit and will be defended vigorously. Management believes that
the resolution of these claims will not have a material adverse effect on the
Company's financial position or results of
Page 8
<PAGE> 11
operations, although the Company will be required to incur legal fees and costs
in defending these lawsuits.
Uncertainty Associated with Health Care Regulations
For the three and nine month periods ended January 31, 1996, 67% and 76%,
respectively, of the Company's revenues were derived from the Company's
management of its outpatient acute psychiatric programs. The remaining
revenues were derived from operations of the Company's case management and
chemical dependency programs. Substantially all of the funds paid to the case
management agencies that the Company is managing are derived from Federal and
State Medicaid funds.
Since substantially all of the patients of the Company's outpatient acute
psychiatric programs are eligible for Medicare, collection of a significant
component of the Company's management fees is dependent upon reimbursement of
claims submitted to fiscal intermediaries by the Hospitals or CMHCs (Providers)
on whose behalf these programs are managed.
The Company maintains a contractual settlement reserve to cover the effect
of primarily two uncertainties: 1) that the Company may not receive full
payment of the management fees owed to it by the Providers during the periodic
review of the Providers' claims by the fiscal intermediaries, and 2) that the
Company may have an obligation to indemnify certain Providers for some portions
of its management fee which may be subject to disallowance upon audit of the
Providers' cost report by fiscal intermediaries.
During the fourth quarter of Fiscal Year 1994, the Company became aware
that fiscal intermediaries for Hospitals and CMHCs had begun a Focused Medical
Review of claims for partial hospitalization services throughout the country.
The Company's initial experience with the Focused Medical Review was that there
were numerous denials of Providers' claims and the denials had an impact on the
Company's cash flow because Providers delayed payment of the Company's
management fee because of the substantial number of denials. On behalf of the
Providers, the Company strenuously disputed these denials, particularly the
interpretations implemented by one singular fiscal intermediary. The initial
review process was particularly complicated by the absence of comprehensive
standards governing the partial hospitalization benefit.
To the extent claims for services have been denied in Programs managed by
the Company, the great majority of the denied claims have been appealed and the
reversal rate has been favorable. The appeals process continues for a
significant number of the denied claims. Generally, to the extent that a
denied claim is not reversed, the Company is not entitled to a management fee
with respect to the denied claim. Management believes that the Company's
reserve for contract settlement should be adequate to offset the negative
impact of unsuccessful appeals of denied claims.
Page 9
<PAGE> 12
The Focused Medical Review of claims for partial hospitalization services
conducted by fiscal intermediaries for the Hospitals and CMHCs has
substantially abated. During Fiscal 1996, the number of denied claims have
been reduced to an insignificant rate. This has occurred as a result of a
number of factors, such as the issuance of a Medicare Program Memorandum by
HCFA during June 1995 (which defines partial hospitalization eligibility and
the scope of covered services), as well as the intensification of the Company's
utilization review and utilization management efforts. As the number of
denials decrease, the impact on cash flow decreases to what management
anticipates will constitute a more normal impact on the Company's cash flow
typical of the conditions which existed prior to the Focused Medical Review.
The Company has been advised by the Health Care Financing Administration
(HCFA) that certain Program-related costs are not allowable for reimbursement.
Although the Company believes that its management fee is fully reimbursable,
there can be no assurances that, upon regulatory or judicial review, the
Company's position will be sustained. If the Company's management fee is not
fully allowed, the Company may be responsible for reimbursement of the amounts
disallowed, pursuant to warranty obligations that exist with certain Hospital
and CMHCs. Even though the Company's financial statements provide a reserve
for any such payments, a short-term obligation to provide reimbursement could
have a material adverse impact upon the Company's liquidity and capital
resources. Management believes, however, that this is unlikely to occur.
Certain factors are, in management's view, likely to lessen the impact of any
such material adverse effect, including the expectation that, if claims arise,
they will arise on a periodic basis over several years; that any disallowance
will merely be offset against obligations already owed by the Provider to the
Company; and that, in certain instances, funds have already been paid into an
escrow account to cover any such eventuality.
In the present period of legislative uncertainty and deficit Federal
spending, financing the Medicare and Medicaid programs will continue to be a
target for reduced spending and the rules and regulations will continue to be
refined and changed. It is impossible to predict what changes will be made
and, therefore, one cannot speculate as to the impact of future changes on the
Company's contracts or revenues. Management believes it is unlikely that
funding will cease for the treatment of psychiatric illness. Further, in view
of the continued emphasis on outpatient treatment programs, management believes
changes in Medicare or Medicaid regulations will not disqualify its outpatient
acute psychiatric program conceptually, although modification of its contracts
or adjustments in its outpatient acute psychiatric programs may be required.
Page 10
<PAGE> 13
PART II - OTHER INFORMATION
ITEM 1 - LEGAL PROCEEDINGS
None
ITEM 2 - CHANGES IN SECURITIES
None
ITEM 3 - DEFAULTS UPON SENIOR SECURITIES
None
ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None
ITEM 5 - OTHER INFORMATION
The management of the Company is not aware of any events required to be
reported hereunder.
ITEM 6 - EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
None
(b) Reports on Form 8-K
None
Page 11
<PAGE> 14
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: March 15, 1996
PMR CORPORATION
BY: Allen Tepper
-------------------------------------
ALLEN TEPPER
President and Chief Executive Officer
(Principal Executive Officer)
BY: Susan Yeagley Sullivan
-------------------------------------
SUSAN YEAGLEY SULLIVAN
Chief Financial Officer
(Principal Financial Officer)
Page 12
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> APR-30-1996
<PERIOD-START> MAY-01-1995
<PERIOD-END> JAN-31-1996
<CASH> 1,688,710
<SECURITIES> 0
<RECEIVABLES> 13,510,787
<ALLOWANCES> 1,005,379
<INVENTORY> 0
<CURRENT-ASSETS> 16,492,632
<PP&E> 673,721
<DEPRECIATION> 817,378
<TOTAL-ASSETS> 19,591,725
<CURRENT-LIABILITIES> 4,843,769
<BONDS> 0
<COMMON> 35,471
0
7,000
<OTHER-SE> 8,505,465
<TOTAL-LIABILITY-AND-EQUITY> 19,591,725
<SALES> 0
<TOTAL-REVENUES> 24,374,956
<CGS> 0
<TOTAL-COSTS> 19,674,822
<OTHER-EXPENSES> 417,832
<LOSS-PROVISION> 645,489
<INTEREST-EXPENSE> 1,330
<INCOME-PRETAX> 837,901
<INCOME-TAX> 344,000
<INCOME-CONTINUING> 493,901
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 493,901
<EPS-PRIMARY> .11
<EPS-DILUTED> .11
</TABLE>
